ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009

Massive Opposition Building To OMB Cuts; Legislative, Court Actions Predicted

February 22, 1985

HPV-Positive Women Over 30 Should Be Retested Within Two Years

September 30, 2011

In Brief: ESMO Names Annual Award Winners

October 10, 2014

DCPC Bard Approves Concepts For New Grant Programs

November 13, 1992

Guttmacher Named NICHD Director

December 18, 2009